{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:06:00Z","timestamp":1790269560696,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81371437"],"award-info":[{"award-number":["81371437"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31171037"],"award-info":[{"award-number":["31171037"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.intimp.2015.10.032","type":"journal-article","created":{"date-parts":[[2015,11,6]],"date-time":"2015-11-06T07:45:14Z","timestamp":1446795914000},"page":"334-343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Immunomodulatory and neuroprotective effects of ginsenoside Rg1 in the MPTP(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) -induced mouse model of Parkinson's disease"],"prefix":"10.1016","volume":"29","author":[{"given":"Ting-ting","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Zu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-gang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan-hua","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2015.10.032_bb0005","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","article-title":"Parkinson's disease","volume":"373","author":"Lees","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2015.10.032_bb0010","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1212\/WNL.66.10_suppl_4.S24","article-title":"The pathogenesis of cell death in Parkinson's disease","volume":"66","author":"Jenner","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.intimp.2015.10.032_bb0015","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","article-title":"Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention","volume":"37","author":"Tansey","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.intimp.2015.10.032_bb0020","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/aje\/kwm260","article-title":"Peripheral inflammatory biomarkers and risk of Parkinson's disease","volume":"167","author":"Chen","year":"2008","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.intimp.2015.10.032_bb0025","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/emm.2006.40","article-title":"Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease","volume":"38","author":"Kim","year":"2006","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.intimp.2015.10.032_bb0030","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.neuro.2012.01.018","article-title":"Peripheral inflammation increases the deleterious effect of CNS inflammation on the nigrostriatal dopaminergic system","volume":"33","author":"Hern\u00e1ndez-Romero","year":"2012","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.intimp.2015.10.032_bb0035","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/imm.12134","article-title":"Innate and adaptive immune responses in neurodegeneration and repair","volume":"141","author":"Amor","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2015.10.032_bb0040","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/187152707781387288","article-title":"Chinese herbs and herbal extracts for neuroprotection of dopaminergic neurons and potential therapeutic treatment of Parkinson's disease","volume":"6","author":"Chen","year":"2007","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.intimp.2015.10.032_bb0045","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11481-014-9569-6","article-title":"Potential neuroprotective activity of ginseng in Parkinson's disease: a review","volume":"10","author":"Gonz\u00e1lez-Burgos","year":"2015","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.intimp.2015.10.032_bb0050","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.neuint.2010.11.004","article-title":"Ginsenoside Rg1 protects against hydrogen peroxide-induced cell death in PC12 cells via inhibiting NF-\u03baB activation","volume":"58","author":"Liu","year":"2011","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.intimp.2015.10.032_bb0055","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.brainres.2004.06.030","article-title":"Ginsenosides Rb1 and Rg1 effects on mesencephalic dopaminergic cells stressed with glutamate","volume":"1021","author":"Radad","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.intimp.2015.10.032_bb0060","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.neuropharm.2006.10.001","article-title":"Neuroprotective effects of ginsenoside-Rg1 in primary nigral neurons against rotenone toxicity","volume":"52","author":"Leung","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.intimp.2015.10.032_bb0065","first-page":"19","article-title":"MPTP mouse models of Parkinson's disease: an update","volume":"1","author":"Meredith","year":"2011","journal-title":"J. Park. Dis."},{"key":"10.1016\/j.intimp.2015.10.032_bb0070","first-page":"135","article-title":"The parkinsonian toxin MPTP: action and mechanism","volume":"16","author":"Przedborski","year":"2000","journal-title":"Restor. Neurol. Neurosci."},{"key":"10.1016\/j.intimp.2015.10.032_bb0075","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/ana.24011","article-title":"Therapeutic prospects for Parkinson disease","volume":"74","author":"Olanow","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.intimp.2015.10.032_bb0080","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson's disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.intimp.2015.10.032_bb0085","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","article-title":"Neuroinflammation in Parkinson's disease: a target for neuroprotection?","volume":"8","author":"Hirsch","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.intimp.2015.10.032_bb0090","first-page":"182","article-title":"Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease","volume":"119","author":"Brochard","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2015.10.032_bb0095","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1755-5949.2010.00208.x","article-title":"Ginsenosides and their CNS targets","volume":"17","author":"Radad","year":"2011","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.intimp.2015.10.032_bb0100","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1527-3458.2007.00023.x","article-title":"Ginsenosides: are any of them candidates for drugs acting on the central nervous system?","volume":"13","author":"Nah","year":"2007","journal-title":"CNS Drug Rev."},{"key":"10.1016\/j.intimp.2015.10.032_bb0105","first-page":"829","article-title":"Protective effect of ginsenoside Rg1 against MPTP-induced apoptosis in mouse substantia nigra neurons","volume":"23","author":"Chen","year":"2002","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2015.10.032_bb0110","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1254\/jphs.CRJ05010X","article-title":"Use of ginseng in medicine with emphasis on neurodegenerative disorders","volume":"100","author":"Radad","year":"2006","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.intimp.2015.10.032_bb0115","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1089\/ars.2009.2460","article-title":"Innate and adaptive immunity for the pathobiology of Parkinson's disease","volume":"11","author":"Stone","year":"2009","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.intimp.2015.10.032_bb0120","first-page":"2484","article-title":"Ginsenoside Rg1 suppressed inflammation and neuron apoptosis by activating PPAR\u03b3\/HO-1 in hippocampus in rat model of cerebral ischemia-reperfusion injury","volume":"8","author":"Yang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.intimp.2015.10.032_bb0125","doi-asserted-by":"crossref","first-page":"770","DOI":"10.2174\/092986712798992066","article-title":"Ginsenoside Rg1 attenuates lipopolysaccharide-induced inflammatory responses via the phospholipase C-\u03b31 signaling pathway in murine BV-2 microglial cells","volume":"19","author":"Zong","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.intimp.2015.10.032_bb0130","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/imm.12233","article-title":"Inflammation in neurodegenerative diseases\u2014an update","volume":"142","author":"Amor","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.intimp.2015.10.032_bb0135","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1093\/brain\/awh625","article-title":"A possible role for humoral immunity in the pathogenesis of Parkinson's disease","volume":"128","author":"Orr","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.intimp.2015.10.032_bb0140","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1001\/archneur.58.10.1580","article-title":"Increase in peripheral CD4 bright+CD8 dull+T cells in Parkinson disease","volume":"58","author":"Hisanaga","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.intimp.2015.10.032_bb0145","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0165-5728(00)00422-7","article-title":"Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism","volume":"113","author":"Bas","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.intimp.2015.10.032_bb0150","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1189\/jlb.0507296","article-title":"Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease","volume":"82","author":"Reynolds","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.intimp.2015.10.032_bb0155","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.4049\/jimmunol.0803982","article-title":"Nitrated {alpha}-synuclein-induced alterations in microglial immunity are regulated by CD4+ T cell subsets","volume":"182","author":"Reynolds","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2015.10.032_bb0160","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.parkreldis.2005.07.005","article-title":"Alterations of T-lymphocyte populations in Parkinson disease","volume":"11","author":"Baba","year":"2005","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.intimp.2015.10.032_bb0165","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/jnr.23253","article-title":"Bacillus Calmette\u2013Guerin vaccine-mediated neuroprotection is associated with regulatory T-cell induction in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease","volume":"91","author":"La\u0107an","year":"2013","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.intimp.2015.10.032_bb0170","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1002\/eji.200737772","article-title":"Historical insights into cytokines","volume":"37","author":"Dinarello","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2015.10.032_bb0175","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.cyto.2012.07.030","article-title":"Inflammatory cytokines and NT-proCNP in Parkinson's disease patients","volume":"60","author":"Koziorowski","year":"2012","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2015.10.032_bb0180","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1600-0404.1999.tb00721.x","article-title":"Association of circulating TNF-alpha and IL-6 with ageing and parkinsonism","volume":"100","author":"Dobbs","year":"1999","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.intimp.2015.10.032_bb0185","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1523\/JNEUROSCI.5321-06.2007","article-title":"Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons","volume":"27","author":"Mount","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.intimp.2015.10.032_bb0190","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00281-013-0382-8","article-title":"Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegeneration","volume":"35","author":"Perry","year":"2013","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.intimp.2015.10.032_bb0195","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1126\/science.1110647","article-title":"Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo","volume":"308","author":"Nimmerjahn","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.intimp.2015.10.032_bb0200","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/ana.10728","article-title":"Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration","volume":"54","author":"McGeer","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.intimp.2015.10.032_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.102.035048","article-title":"Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention","volume":"304","author":"Liu","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.intimp.2015.10.032_bb0210","doi-asserted-by":"crossref","first-page":"R84","DOI":"10.1093\/hmg\/ddn104","article-title":"Cellular repair of CNS disorders: an immunological perspective","volume":"17","author":"Chen","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.intimp.2015.10.032_bb0215","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ana.20369","article-title":"Blood\u2013brain barrier dysfunction in parkinsonian midbrain in vivo","volume":"57","author":"Kortekaas","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.intimp.2015.10.032_bb0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.55782\/ane-1999-1289","article-title":"MHC class II positive microglia and lymphocytic infiltration are present in the substantia nigra and striatum in mouse model of Parkinson's disease","volume":"59","author":"Kurkowska-Jastrzebska","year":"1999","journal-title":"Acta Neurobiol. Exp. (Wars)"},{"key":"10.1016\/j.intimp.2015.10.032_bb0225","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.expneurol.2012.08.020","article-title":"Brain-resident microglia predominate over infiltrating myeloid cells in activation, phagocytosis and interaction with T-lymphocytes in the MPTP mouse model of Parkinson disease","volume":"238","author":"Depboylu","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.intimp.2015.10.032_bb0230","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1749-6632.2003.tb07478.x","article-title":"The role of glial reaction and inflammation in Parkinson's disease","volume":"991","author":"Hirsch","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.intimp.2015.10.032_bb0235","doi-asserted-by":"crossref","first-page":"36280","DOI":"10.1074\/jbc.M606698200","article-title":"Ginsenoside-Rg1 induces vascular endothelial growth factor expression through the glucocorticoid receptor-related phosphatidylinositol 3-kinase\/Akt and beta-catenin\/T-cell factor-dependent pathway in human endothelial cells","volume":"281","author":"Leung","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2015.10.032_bb0240","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/sj.bjp.0706640","article-title":"Activation of insulin-like growth factor I receptor-mediated pathway by ginsenoside Rg1","volume":"147","author":"Chen","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2015.10.032_bb0245","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1242\/dmm.015362","article-title":"Insulin-like growth factor-1 induces regulatory T cell-mediated suppression of allergic contact dermatitis in mice","volume":"7","author":"Johannesson","year":"2014","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.intimp.2015.10.032_bb0250","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/(SICI)1097-4547(19970301)47:5<531::AID-JNR8>3.0.CO;2-I","article-title":"Insulin-like growth factor-I treatment reduces immune cell responses in acute non-demyelinative experimental autoimmune encephalomyelitis","volume":"47","author":"Liu","year":"1997","journal-title":"J. Neurosci. Res."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757691530165X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156757691530165X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T08:04:24Z","timestamp":1718179464000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156757691530165X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S156757691530165X"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2015.10.032","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunomodulatory and neuroprotective effects of ginsenoside Rg1 in the MPTP(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) -induced mouse model of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2015.10.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}